Pathological Complete Response Rate (pCR) in Patients with Triple Negative Breast Cancer (TNBC) who Received Either Platinum and Taxane Containing Regimen or Taxane Containing Regimen Alone, Along with Anthracyclines: Real Life Results from South East London Accountable Cancer Network
Purpose: To determine the pCR in patients with TNBC according to the neoadjuvant chemotherapy (NACT) they received; taxane-based chemotherapy alone and anthracyclines or taxane-based chemotherapy together with carboplatin and antracyclines.
Source: Clinical Oncology - Category: Radiology Authors: E. Tsotra, R. Hale, N. Yoganayagam, R. Nathan Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Radiology